Sling Therapeutics

Ann Arbor biotech developing linsitinib, an oral drug for thyroid eye disease now in Phase 3.

View on the globe

$123MEquity raised in 2025–20262025 — · 2026 $123M · 1 equity round
$123MEquity raised, all time1 equity round sourced so far
—Latest valuationnot disclosed

Rounds over time log-scaled amounts

Funding history: 1 round from 16 Sep 2026 to 16 Sep 2026, $123M equity disclosed. Earlier rounds exist but are not sourced.16 Sep 2026: Series C, $123M$10M$30M$100M$300M$1BEarlier rounds exist but are not sourced yet← earlier rounds not sourcedQ2Q3Q42027Q2Equity round16 Sep 2026 · Series C · $123M · led by ForbionSeries C · $123M
Funding history: 1 round from 16 Sep 2026 to 16 Sep 2026, $123M equity disclosed. Earlier rounds exist but are not sourced.16 Sep 2026: Series C, $123M$10M$30M$100M$300M$1BEarlier rounds exist but are not sourced yetearlier rounds not sourcedQ2Q3Q42027Q2Equity round16 Sep 2026 · Series C · $123M · led by Forbion$123M

Funding history 1 round · 2 sources

Earlier rounds not yet sourced. Sling Therapeutics raised before 16 Sep 2026; only the rounds below are sourced so far, so its all-time equity total understates its history.

  1. Series C
    Amount$123M
    Post-money—
    ✓ Confirmed
    Lead
    Forbion
    Also
    TPG Life Sciences Innovations, Sectoral Asset Management
    Note
    Valuation not disclosed. Two independent trade reports agree on amount, date, lead and co-investors: BioSpace (listed secondary) and BioPharma Dive (not on the README secondary list; counted as secondary here). Fierce Biotech returned 403 and the company release was not reached; a confirmation from the company release would be preferable. The Series A ($35M, 2022, per search summaries, not opened) is not written.
    Sources
  2. Earlier rounds not yet sourced

Investors 3

  • Forbion1
  • Sectoral Asset Management
  • TPG Life Sciences Innovations

Highlighted investors led at least one equity round; the number is equity rounds taken part in.

Related companies shared investors

Figures in USD at the time of each round. See the methodology for how rounds are sourced and verified. Sling Therapeutics and its logo are trademarks of their owners, used here for identification only.